- Home
- About Us
About Us
- Home
- About Us
About Us
Innovation in Epidemic Response
Who we are
We are a semi-autonomous inter-government a not-for-profit entity, that coordinates partners across agencies and departments locally and internationally to conduct epidemic responsive research.
ICER was formed in November 2022 as a collaboration of local and international partners who included Makerere University Lung Institute MLI, UVRI, IDI, etc
What we do
ICER conducts high quality research in epidemics and other diseases of public health importance through collaboration and partnerships.
We leverage on our unique position within the global health and R&D ecosystems to address market failures
We leverage on our unique position within the global health and R&D ecosystems to address market failures
Our Mission
To support research entities [institutions, agencies, and governments] to maintain, improve, and sustain the health of the people through development of evidence-based countermeasures for rapid prevention, detection, and response to emerging and re-emerging diseases of epidemic- pandemic potential.
Vision
Research as an integral part of epidemic preparedness and response
Aim
To rapidly and efficiently generate and disseminate research evidence before, during, and after emerging and re-emerging infectious diseases epidemics
Goal
ICER’s goal is to foster interdisciplinary research collaboration to enable rapid infectious diseases epidemic detection, containment, and optimized clinical care delivery that will inform policies to improve health outcomes
Result Focused Research Approaches
Strategic Objectives
Contingent upon political/governments approvals and the requisite funding, the consortium proposes the following activities objectified towards institutionalizing ICER as a platform for evidence-based mitigation of outbreaks, epidemics and pandemics.
- Mobilize support and resources towards national epidemics priority research areas from local and international partners/collaborators, and coordinate funding proposal submissions on epidemics research from consortium members
- Strengthen capacity for patient centered epidemic response-research in emerging and re-emerging diseases at institutional levels
- Support development of pre-approved generic protocols to facilitate the conduct of real-time clinical trials to evaluate candidate vaccines, diagnostics, therapeutics and related priority research during outbreaks and epidemics
- Promote sustainable community engagement and dissemination of research findings and tailored information products to various stakeholders for improved understanding, acceptance, and awareness of research during outbreaks and epidemics
- Contribute to and facilitate the enhancement of national and international frameworks for collaborative and systematic acquisition, storage, access, sharing, use, and disposal of biodata, genomic sequencing data, and bio-specimens from outbreaks and epidemics